Naito T, Tanaka H, Naoe Y, Taniuchi I. Transcriptional control of T-cell development. Int Immunol 2011; 23: 661–668.
Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001; 15: 763–774.
Williams CJ, Naito T, Arco PG-d, Seavitt JR, Cashman SM, De Souza B et al. The chromatin remodeler Mi-2β is required for CD4 expression and T cell development. Immunity 2004; 20: 719–733.
Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 2009; 9: 91–105.
Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6: 838–849.
Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410: 116–120.
Barski A, Cuddapah S, Cui K, Roh T-Y, Schones DE, Wang Z et al. High-Resolution Profiling of Histone Methylations in the Human Genome. Cell 2007; 129: 823–837.
Lohmann F, Loureiro J, Su H, Fang Q, Lei H, Lewis T et al. KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. Stem Cells 2010; 28: 201–212.
Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci 2006; 103: 19176–19181.
Dodge JE, Kang Y-K, Beppu H, Lei H, Li E. Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 2004; 24: 2478–2486.
Ceol CJ, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando DA, Battisti V et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011; 471: 513–517.
Fritsch L, Robin P, Mathieu JRR, Souidi M, Hinaux H, Rougeulle C et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 2010; 37: 46–56.
Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I et al. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J 2004; 23: 605–615.
Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC et al. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J Exp Med 2010; 207: 915–922.
Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 2012; 487: 249–253.
Thomas LR, Miyashita H, Cobb RM, Pierce S, Tachibana M, Hobeika E et al. Functional analysis of histone methyltransferase G9a in B and T lymphocytes. J Immunol 2008; 181: 485–493.
Taniuchi I, Sunshine MJ, Festenstein R, Littman DR. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol Cell 2002; 10: 1083–1096.
Santoni de Sio FR, Barde I, Offner S, Kapopoulou A, Corsinotti A, Bojkowska K et al. KAP1 regulates gene networks controlling T-cell development and responsiveness. FASEB J 2012; 26: 4561–4575.
Zhou X-F, Yu J, Chang M, Zhang M, Zhou D, Cammas F et al. TRIM28 mediates chromatin modifications at the TCRα enhancer and regulates the development of T and natural killer T cells. Proc Natl Acad Sci 2012; 109: 20083–20088.
Chikuma S, Suita N, Okazaki I-M, Shibayama S, Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol 2012; 13: 596–603.
Dodge JE, Kang YK, Beppu H, Lei H, Li E. Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 2004; 24: 2478–2486.
Wang X, Werneck MBF, Wilson BG, Kim H-J, Kluk MJ, Thom CS et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest 2011; 121: 3834–3845.
Yamashita I, Nagata T, Tada T, Nakayama T. CD69 cell surface expression identifies developing thymocytes which audition for T cell antigen receptor-mediated positive selection. Int Immunol 1993; 5: 1139–1150.
Karimi MM, Goyal P, Maksakova IA, Bilenky M, Leung D, Tang JX et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 2011; 8: 676–687.
Wong QW-L, Li J, Ng SR, Lim SG, Yang H, Vardy LA. RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors. RNA Biol 2014; 11: 33–41.
Sandor M, Galon J, Takacs L, Tatsumi Y, Mueller AL, Sautes C et al. An alternative Fc gamma-receptor ligand: potential role in T-cell development. Proc Natl Acad Sci 1994; 91: 12857–12861.
Daëron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S et al. The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995; 3: 635–646.
Rodewald H-R, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL. A population of early fetal thymocytes expressing FcγRIIIII contains precursors of T lymphocytes and natural killer cells. Cell 1992; 69: 139–150.
Collazo MM, Wood D, Paraiso KHT, Lund E, Engelman RW, Le C-T et al. SHIP limits immunoregulatory capacity in the T-cell compartment. Blood 2009; 113: 2934–2944.
Jensen WA, Marschner S, Ott VL, Cambier JC. FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization. Biochem Soc Trans 2001; 29: 840–846.
Alam A, Cohen LY, Aouad S, Sékaly R-P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999; 190: 1879–1890.
Salek M, McGowan S, Trudgian DC, Dushek O, de Wet B, Efstathiou G et al. Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3ζ and ZAP-70 tyrosine phosphorylation. PLoS ONE 2013; 8: e77423.
Schoppee Bortz PD, Wamhoff BR. Chromatin Immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCR. PLoS ONE 2011; 6: e26015.
Veri M-C, Burke S, Huang L, Li H, Gorlatov S, Tuaillon N et al. Therapeutic control of B cell activation via recruitment of Fcγ receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold. Arthritis Rheum 2010; 62: 1933–1943.